Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy

Madeline Denison,Santana P. Garcia,Alexander Ullrich,Izabela Podgorski,Heather Gibson,Claudia Turro,Jeremy J. Kodanko
DOI: https://doi.org/10.1021/acs.inorgchem.4c01008
IF: 4.6
2024-04-16
Inorganic Chemistry
Abstract:Dysregulated cathepsin activity is linked to various human diseases including metabolic disorders, autoimmune conditions, and cancer. Given the overexpression of cathepsin in the tumor microenvironment, cathepsin inhibitors are promising pharmacological agents and drug delivery vehicles for cancer treatment. In this study, we describe the synthesis and photochemical and biological assessment of a dual-action agent based on ruthenium that is conjugated with a cathepsin inhibitor, designed for...
chemistry, inorganic & nuclear
What problem does this paper attempt to address?